Stay updated on Dolutegravir in Pregnancy Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir in Pregnancy Clinical Trial page.

Latest updates to the Dolutegravir in Pregnancy Clinical Trial page
- Check3 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAccess to the study page now returns a 403 Forbidden error page, replacing the previous study content. This indicates an access/permissions issue rather than a content update to the study record.SummaryDifference19%

- Check45 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6. This appears to be a minor administrative update rather than a change to the study content.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page revision was updated from v3.6.4 to v3.6.5, signaling a maintenance update to the ClinicalTrials.gov page. This update does not appear to modify the study content or data.SummaryDifference0.1%

- Check80 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a small update to the page template or content management system. This appears to be a maintenance release rather than a change to study data or public-facing content.SummaryDifference0.1%

- Check102 days agoChange DetectedA new page revision tag v3.6.3 was added, replacing the previous v3.6.2 in the page footer.SummaryDifference0.1%

Stay in the know with updates to Dolutegravir in Pregnancy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir in Pregnancy Clinical Trial page.